Hartig Drug Expands Offerings with Nefense Nasal Care Products

Hartig Drug Company has announced the addition of Nefense® nasal care products to its shelves at select locations across Iowa, Illinois, and Wisconsin. This expansion provides customers with new drug-free alternatives for daily nasal hygiene, catering to a growing demand for non-medicated solutions.

The Nefense lineup includes hypochlorous acid nasal sprays designed for adults, children, and infants, as well as a xylitol-based spray. These products offer a gentle yet effective approach to nasal care without the use of active pharmaceutical ingredients typically found in decongestants. By offering options across different age groups, Hartig Drug aims to meet the diverse needs of families seeking safe and natural ways to maintain respiratory health.

Published randomized clinical research has evaluated the efficacy of low-concentration hypochlorous acid nasal irrigation for managing chronic sinonasal symptoms and allergic rhinitis. While these studies do not specifically test Nefense-branded products, they provide scientific backing for the active ingredient used in the sprays. This evidence may reassure consumers looking for clinically informed choices in over-the-counter nasal care.

Hartig Drug, a family-owned pharmacy and retail company founded in Dubuque, Iowa, in 1904, continues to emphasize personalized service and strong community ties. The addition of Nefense products aligns with the company's commitment to offering health and wellness products that support the well-being of its customers. With locations serving communities throughout Iowa, Illinois, and Wisconsin, Hartig Drug ensures that these new items are readily accessible to a broad regional audience.

Nefense, Natural Wellness & Defense, is a Dubuque-based nasal wellness company focused on daily nasal hygiene and airway care. Developed under the direction of Richard Downs, DDS, the product portfolio includes HypoNasal, HypoNasal Junior, HypoBaby, and XyloClean. These formulations are designed for routine nasal care, providing a proactive approach to maintaining clear airways and better breathing.

Consumers interested in learning more about the science behind these products can refer to the clinical research that has been published in peer-reviewed journals. While the studies do not directly evaluate Nefense products, they offer insights into the potential benefits of hypochlorous acid in nasal health. For additional information about the product range, customers can visit nefense.com.

This strategic move by Hartig Drug underscores a broader trend in the retail pharmacy sector toward integrating natural and preventive health solutions. By making Nefense available, Hartig Drug not only diversifies its product portfolio but also positions itself as a responsive retailer that listens to consumer preferences for non-pharmaceutical options. The availability of these products at select locations may pave the way for further expansion if customer response is favorable, potentially influencing how other regional pharmacies approach their nasal care selections.